Key result
In diabetes patients, blood pressure of 130-139/80-89 mm Hg was associated with increased risk of cardiovascular disease (HR 1.12; 95% CI 1.04-1.20) compared to <120/<80 mm Hg.
Why the study?
The association between blood pressure defined by the 2017 ACC/AHA guidelines and cardiovascular disease or chronic kidney disease in patients with diabetes mellitus remained unclear.
Do higher blood pressure categories according to the 2017 ACC/AHA guidelines increase the risk of cardiovascular disease and chronic kidney disease in patients with diabetes mellitus?
Cohort (n=490,352)
Yes
Do higher blood pressure categories according to the 2017 ACC/AHA guidelines increase the risk of cardiovascular disease and chronic kidney disease in patients with diabetes mellitus?
Effect estimate: HR 1.12 (95% CI 1.04-1.20)
Higher blood pressure categories defined by the 2017 ACC/AHA guidelines are associated with increased risks of CVD, CKD, cerebrovascular disease, and CVD mortality in patients with diabetes mellitus.
BP 130-139/80-89 mm Hg association in diabetes warrants no practice change; leaves open optimal targets for RCTs.
The association between blood pressure (BP) defined by the 2017 American College of Cardiology/American Heart Association Hypertension Clinical Practice Guidelines with cardiovascular disease (CVD) and chronic kidney disease in patients with diabetes mellitus remains unclear. This study used the National Health Insurance Database of Korea that has health information of 8 922 940 persons who were screened from 2009 to 2014. We determined the BP status of 490 352 diabetes mellitus: level 1 (systolic <120 mm Hg and diastolic <80 mm Hg), level 2 (systolic 120-129 mm Hg and diastolic <80 mm Hg), level 3 (systolic 130-139 mm Hg or diastolic 80-89 mm Hg), and level 4 (systolic ≥140 mm Hg or diastolic ≥90 mm Hg). Over a mean follow-up of 5 years, 6508 CVD events (1.3%), 14 318 cases of chronic kidney disease development (2.9%), 9094 cerebrovascular events (2.0%), and 1150 CVD mortalities (0.2%) occurred. Compared with people with BP levels 1, the adjusted hazard ratios for CVD in people with BP levels 2, 3, and 4 were 1.07 (95% CI, 0.98-1.16), 1.12 (95% CI, 1.04-1.20), and 1.17 (95% CI, 1.08-1.26), respectively. There were also increased risks of chronic kidney disease (1.18 [95% CI, 1.12-1.24] and 1.22 [95% CI, 1.15-1.29]), cerebrovascular disease (1.21 [95% CI, 1.14-1.29] and 1.52 [95% CI, 1.42-1.63]), and CVD mortality (1.31 [95% CI, 1.09-1.56] and 1.91 [95% CI, 1.58-2.32]) among subjects with BP levels 3 and 4 compared with those with BP level 1. These findings provide evidence supporting the 2017 American College of Cardiology/American Heart Association Hypertension Clinical Practice Guidelines for BP targets in diabetes mellitus patients.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) conducted a cohort in Diabetes Mellitus (n=490,352). Blood pressure levels 2, 3, and 4 vs. Blood pressure level 1 (systolic <120 mm Hg and diastolic <80 mm Hg) was evaluated on Cardiovascular disease (CVD) (HR 1.12, 95% CI 1.04-1.20). In diabetes patients, blood pressure of 130-139/80-89 mm Hg was associated with increased risk of cardiovascular disease (HR 1.12; 95% CI 1.04-1.20) compared to <120/<80 mm Hg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: